Clinical manifestations of invasive pneumococcal disease by vaccine and non-vaccine types
نویسندگان
چکیده
منابع مشابه
Clinical manifestations of invasive pneumococcal disease by vaccine and non-vaccine types.
Pneumococcal conjugated vaccines (PCVs) have shown protection against invasive pneumococcal disease by vaccine serotypes, but an increase in non-vaccine serotype disease has been observed. Type-specific effects on clinical manifestation need to be explored. Clinical data from 2096 adults and 192 children with invasive pneumococcal disease were correlated to pneumococcal molecular serotypes. Inv...
متن کاملPneumococcal Conjugate Vaccine and Clinically Suspected Invasive Pneumococcal Disease.
OBJECTIVE Ten-valent pneumococcal conjugate vaccine (PCV10) was earlier shown to reduce clinically suspected, non-laboratory-confirmed invasive pneumococcal disease (IPD) in a cluster-randomized trial (the Finnish Invasive Pneumococcal disease trial). PCV10 was introduced into the Finnish national vaccination program in September 2010 using a 3-dose schedule. We evaluated the impact of PCV10 on...
متن کاملPneumococcal Vaccine- clinical utility
Streptococcus pneumoniae (pneumococcus) is a Gram-positive diplococcus responsible for a spectrum of clinical syndrome including non-invasive infections such as paranasal sinusitis, otitis media and lobar pneumonia as well as invasive diseases, such as bacteremic pneumonia and meningitis. Pneumococcus is the most common cause of community-acquired pneumonia (CAP) in both ambulatory and hospital...
متن کاملInvasive pneumococcal disease in children: Risk factors and vaccine effectiveness
Invasive pneumococcal disease (IPD) has high morbidity and mortality worldwide. The overall incidence of IPD in Catalonia in 2005-2009 was 16.6 per 100,000 persons-year, 66.4 in children aged < 2 years and 50.7 in children aged 2-4 years. 7-valent pneumococcal conjugate vaccine (PCV7) coverage in Catalonia is intermediate. A prospective matched case-control study in children aged 3-59 months tr...
متن کاملInvasive pneumococcal disease after implementation of 13-valent conjugate vaccine.
OBJECTIVE To examine whether there is a different clinical profile and severity of invasive pneumococcal disease (IPD) in children caused by nonvaccine types in the era of 13-valent pneumococcal conjugate vaccine (PCV13). METHODS Observational study of childhood IPD in Massachusetts based on state public health surveillance data comparing pre-PCV13 (2007-2009) and post-PCV13 (2010-2012) eras....
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Respiratory Journal
سال: 2014
ISSN: 0903-1936,1399-3003
DOI: 10.1183/09031936.00080814